The Japan Times21h ago
Bain Capital-owned Tanabe Pharma is on the hunt for licensing deals abroad to bring medicines into Japan, betting that unmet patient demand and easing regulations will fuel growth. https://www.japantimes.co.jp/business/2026/03/26/companies/tanabe-pharma-licensing-deals-abroad/?utm_medium=Social&utm_source=mastodon #business #companies #tanabepharma #pharmaceuticals #medicine #bain
Bain-owned Tanabe Pharma targets global deals to fuel growth

A new team of around eight people in the U.S., in addition to an existing team in Japan, is sourcing therapies globally, particularly in rare diseases.

The Japan Times